Bachem Holding AG (BCHMY)
OTC
Closed
Aug 21, 2026
Day's Range
9.2552 wk Range
5.97Overview - BCHMY - Bachem Holding AG
Key Statistics
Valuation
Enterprise Value
9.07B
P/E (Trailing)
‪37.80‬
Price / Sales (TTM)
‪9.99‬
Price / Book
‪3.98‬
EV / EBITDA
‪34.43‬
Profitability
Profit Margin
‪21.02%‬
Operating Margin
‪16.58%‬
Return on Assets
‪4.54%‬
Return on Equity
‪10.62%‬
Ownership
Shares Outstanding
74.93M
Float
707.79M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪9.21‬
200-Day Avg
‪8.50‬
Dividends
Payout Ratio
‪46.05%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BCHMY - Bachem Holding AG
Peers - BCHMY - Bachem Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - BCHMY - Bachem Holding AG
About
Bachem Holding AG is a leading company in the pharmaceutical and biotechnology sectors, specializing in the development and manufacturing of peptides and oligonucleotides. Its primary function is to provide research-grade and custom synthesis products to the life sciences industry, playing a critical role in drug…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
